Glucagon‐like peptide‐1 receptor analogues in renal transplant recipients with diabetes: Medium term follow of patients from a single UK centre.
| Autor: | Mallik, Ritwika, Ali, Omer, Casabar, Mahalia, Mukuba, Dorcas, Byrne, Connor, McCafferty, Kieran, Yaqoob, M. Magdi, Chowdhury, Tahseen A. |
|---|---|
| Předmět: |
DIABETES complications
HYPERTENSION risk factors PATIENT aftercare DIABETIC neuropathies KIDNEY transplantation DIABETES PATIENTS SURGICAL complications DISEASES WEIGHT gain SURVIVAL analysis (Biometry) HYPOGLYCEMIA GLUCAGON-like peptide-1 agonists DIABETIC retinopathy TRANSPLANTATION of organs tissues etc. DISEASE risk factors |
| Zdroj: | Diabetic Medicine; May2023, Vol. 40 Issue 5, p1-3, 3p |
| Abstrakt: | The article discusses a study which examined outcomes of a cohort of renal transplant recipients with diabetes from a single centre with 12 months follow-up from commencing glucagon-like peptide-1 receptor analogues (GLP-1RAs) therapy. Topics include factors that contribute to development of pos-transplant diabetes mellitus (PTDM), changes in metabolic and biochemical indices over one and two years, and reports of GLP1-RA use in transplant recipients. |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text